Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

pers

Personalised medicine in oncology: Where are we now?

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Feature

Novartis appoints Alessandra Dorigo as General Manager

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alessandra Dorigo has been appointed as the new General Manager UK, Ireland, Baltics, and Nordics for Novartis Advanced Accelerator Applications …
Appointment
close-up-of-female-hands-holding-medication-bottle-royalty-free-image-1612294037

Exploring the potential of drug repurposing

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug repurposing

Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …
Feature
credit_-_daniel_leal-olivas-afp

Astellas receives positive CHMP opinion for symptomatic anaemia drug

June 28, 2021 Sales and Marketing Astellas, CKD, anaemia

Astellas and FibroGen have announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted …
News
biogen_austria_238

Samsung Bioepis & Biogen receive positive CHMP opinion for ranibizumab biosimilar

June 28, 2021 Sales and Marketing EC, EMA, EU, biosimilars

Samsung Bioepis and Biogen have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …
News
lilly_entrance_web

Eli Lilly’s Type 2 diabetes drug outperforms semaglutide in trials

June 28, 2021 Sales and Marketing Eli Lilly, semaglutide, type 2 diabetes

Eli Lilly has announced that the SURPASS-2 clinical trial has shown tirzepatide achieved superior HbA1C and body weight reductions compared …
News
laboratory-testing-az

Polyphor’s future in question after co-primary endpoint in breast cancer study missed

June 28, 2021 Sales and Marketing Primary Endpoint, breast cancer

Swiss biopharmaceutical company, Polyphor, has announced that its global Phase III study, FORTRESS, evaluating balixafortide (POL6326) in combination with eribulin …
News

Medical cannabis formulation kills breast cancer cells in trial

June 28, 2021 Sales and Marketing breast cancer, medical cannabis, oncology

UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …
News
astrazeneca_plaque_web

AstraZeneca ordered to deliver 50 million vaccine doses to EU

June 21, 2021 Sales and Marketing

A Belgian court has instructed AstraZeneca to deliver 50 million COVID-19 shots to the European Union following a dispute on …
News

EU approves Onureg for patients with acute myeloid leukemia

June 21, 2021 Sales and Marketing

The European Commission has approved Onureg as frontline oral maintenance therapy for patients with a broad range of acute myeloid …
News

Alzheimer’s drug approval: Advocacy group calls for FDA resignations

June 21, 2021 Sales and Marketing

Public Citizen, the US consumer advocacy group, has called for the resignation of three top FDA officials following the approval …
News
novartis_window

Novartis’s Zolgensma for SMA shows ‘extraordinary’ results

June 21, 2021 Sales and Marketing

New late-breaker data from the Phase III trial for Zolgensma, the world’s most expensive drug, has shown positive results. Zolgensma …
News
sanofi_hq__boetie_hall_web

EU approves Aubagio for children living with MS

June 21, 2021 Sales and Marketing

The EU has approved Aubagio (teriflunomide) for the treatment of paediatric patients 10 to 17 years of age with relapsing-remitting …
News
janssen_latest_logo_on_sign_closer

Janssen CLL treatment combination sees success in trials

June 14, 2021 Sales and Marketing CLL, Janssen

Janssen has announced positive data from its Phase III GLOW study, with the combination of imbruvica (ibrutinib) plus venetoclax (I+V) …
News
astrazeneca_sign_sky

EMA official recommends avoiding AstraZeneca vaccine

June 14, 2021 Sales and Marketing

A senior executive at the EMA recommended abandoning the use of the AstraZeneca vaccine in the EU where alternatives are …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025